VidaMed

Vidamed developed a non-surgical therapy designed to deliver low-level, precisely controlled radiofrequency energy directly to the prostrate to diminish obstructing tissue associate with Benign Prostatic Hyperplasia (BPH).

The company was acquired by Medtronic.